GIP Receptor Antagonist Studies in Humans

NCT02747472 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Glucose Metabolism

Interventions

DRUG: GIP-A
DRUG: GIP(1-42)
OTHER: Saline

Sponsor

University Hospital, Gentofte, Copenhagen

Collaborators

[object Object]